AJO LP’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-3,833
| Closed | -$632K | – | 150 |
|
2020
Q4 | $632K | Sell |
3,833
-188,502
| -98% | -$31.1M | 0.07% | 200 |
|
2020
Q3 | $27.4M | Sell |
192,335
-128,794
| -40% | -$18.4M | 0.29% | 101 |
|
2020
Q2 | $35.4M | Sell |
321,129
-65,588
| -17% | -$7.24M | 0.32% | 90 |
|
2020
Q1 | $38.6M | Sell |
386,717
-76,770
| -17% | -$7.66M | 0.35% | 91 |
|
2019
Q4 | $69.2M | Buy |
463,487
+150,763
| +48% | +$22.5M | 0.41% | 84 |
|
2019
Q3 | $40.1M | Sell |
312,724
-26,887
| -8% | -$3.45M | 0.23% | 122 |
|
2019
Q2 | $48.4M | Buy |
339,611
+11,245
| +3% | +$1.6M | 0.25% | 121 |
|
2019
Q1 | $46.9M | Buy |
328,366
+153,623
| +88% | +$22M | 0.24% | 116 |
|
2018
Q4 | $21.7M | Sell |
174,743
-3,698
| -2% | -$458K | 0.12% | 167 |
|
2018
Q3 | $30M | Sell |
178,441
-2,139
| -1% | -$360K | 0.14% | 156 |
|
2018
Q2 | $31.1M | Sell |
180,580
-3,560
| -2% | -$613K | 0.14% | 156 |
|
2018
Q1 | $27.8M | Buy |
184,140
+1,847
| +1% | +$279K | 0.13% | 161 |
|
2017
Q4 | $24.5M | Buy |
182,293
+176,324
| +2,954% | +$23.7M | 0.11% | 173 |
|
2017
Q3 | $873K | Hold |
5,969
| – | – | ﹤0.01% | 488 |
|
2017
Q2 | $928K | Buy |
+5,969
| New | +$928K | ﹤0.01% | 497 |
|
2017
Q1 | – | Sell |
-9,651
| Closed | -$1.05M | – | 555 |
|
2016
Q4 | $1.05M | Buy |
+9,651
| New | +$1.05M | ﹤0.01% | 414 |
|
2016
Q2 | – | Sell |
-1,686
| Closed | -$220K | – | 507 |
|
2016
Q1 | $220K | Hold |
1,686
| – | – | ﹤0.01% | 471 |
|
2015
Q4 | $237K | Buy |
+1,686
| New | +$237K | ﹤0.01% | 504 |
|
2014
Q4 | – | Sell |
-2,500
| Closed | -$401K | – | 465 |
|
2014
Q3 | $401K | Sell |
2,500
-5,100
| -67% | -$818K | ﹤0.01% | 385 |
|
2014
Q2 | $1.12M | Sell |
7,600
-5,100
| -40% | -$750K | ﹤0.01% | 354 |
|
2014
Q1 | $1.76M | Sell |
12,700
-66,100
| -84% | -$9.17M | 0.01% | 305 |
|
2013
Q4 | $9.97M | Buy |
78,800
+14,300
| +22% | +$1.81M | 0.04% | 216 |
|
2013
Q3 | $5.93M | Buy |
+64,500
| New | +$5.93M | 0.03% | 264 |
|